FDA Adverse Event Injury Summary report: N

SODIUM CHLORIDE INHALATION SOLUTION, USP, 0.9% 3ML

MDR report key: 21686181 · Received March 25, 2025

Report

Report Number
3001237796-2024-00138
Event Type
Injury
Date Received
March 25, 2025
Date of Event
December 27, 2024
Report Date
March 25, 2025
Manufacturer
THE RITEDOSE CORPORATION
Product Code
CAF
UDI-DI
00376204300032
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
003

Narratives

Description of Event or Problem · 0

THIS SPONTANEOUS REPORT FROM THE UNITED STATES WAS REPORTED BY A 66-YEAR-OLD FEMALE PATIENT WHO EXPERIENCED INFLUENZA, NO MUSCLE IN LEGS, HAD TO USE SOME OF THE HALF DOSES OF SODIUM CHLORIDE INHALATION SOLUTION 0.9% AND COMPLAINED THAT 85 VIALS OUT OF 100 VIALS IN THE PACKAGE WERE ONLY FILLED HALFWAY AND VIALS HAVE WATER BUBBLES. CO-SUSPECT PRODUCT INCLUDED BROM-PSE-DM (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL, DEXTROMETHORPHAN HYDROBROMIDE). ON (B)(6)2024, THE PATIENT PICKED UP HER PRESCRIPTION. ON AN UNSPECIFIED DATE IN (B)(6) 2024, THE PATIENT INITIATED THE SODIUM CHLORIDE INHALATION SOLUTION 0.9%, AS PRESCRIBED, THREE TIMES A DAY AND UP TO FOUR ADDITIONAL TIMES AS NEEDED FOR HER COPD. THE PATIENT HAD BEEN TAKING SODIUM CHLORIDE INHALATION SOLUTION 0.9% EVERY 8 TO 12 HOURS AS NEEDED FOR COPD/ EMPHYSEMA FOR SEVERAL YEARS. ON (B)(6)2024, THE PATIENT DISCOVERED THAT 85 OUT OF THE 100 VIALS IN THE PACKAGE WERE ONLY FILLED HALFWAY, RAISING CONCERNS ABOUT VOLUME INCONSISTENCIES. THE PATIENT NOTICED THE ISSUE AFTER REALIZING THAT THE VIALS WERE RUNNING OUT QUICKLY AND THAT WATER BUBBLES WERE INSIDE. IT WAS REPORTED THAT SHE HAD BEEN FEELING VERY ILL, REQUIRING A VISIT TO HER DOCTOR WHILE BEING ON OXYGEN AND EXPERIENCING BREATHING DIFFICULTIES. AT THE TIME OF REPORTING, SHE HAD ONLY TWO FULL VIALS REMAINING AND HAD TO USE SOME OF THE PARTIALLY FILLED VIALS, RESULTING IN REDUCED DOSES. THE PATIENT STATED THAT SHE DID NOT RETURN THE PRODUCT AS SHE HAD ALREADY FINISHED IT., SHE STOPPED USING SODIUM CHLORIDE INHALATION SOLUTION 0.9% ON AN UNSPECIFIED DATE IN (B)(6) 2024. ON (B)(6)2024, SHE WAS HOSPITALIZED FOR INFLUENZA AND WAS INFORMED BY HER DOCTORS THAT HER FLU WAS CAUSED BY EXCESSIVE STEROID USE (PREDNISONE) AND ELEVATED CARBON DIOXIDE LEVELS IN HER BODY. SHE REPORTED FEELING AS THOUGH SHE HAD NO MUSCLE STRENGTH IN HER LEGS. ON (B)(6)2025, SHE WAS TRANSFERRED TO A REHABILITATION FACILITY AND WAS DISCHARGED HOME ON (B)(6)2025. DURING HER HOSPITALIZATION, THE PATIENT WAS WEANED OFF STEROIDS, AND SODIUM CHLORIDE INHALATION SOLUTION 0.9% WAS NOT REINITIATED. NO ADDITIONAL INFORMATION WAS AVAILABLE AT THE TIME OF REPORTING. ACTION TAKEN WITH SODIUM CHLORIDE INHALATION SOLUTION 0.9% WAS DRUG WITHDRAWN. THE OUTCOME OF EVENTS INFLUENZA AND NO MUSCLE IN MY LEGS WAS UNKNOWN. THE OUTCOME OF THE EVENTS HAD TO USE SOME OF THE HALF DOSES, 85 VIALS OUT OF 100 VIALS IN THE PACKAGE ARE ONLY FILLED HALFWAY AND VIALS HAVE WATER BUBBLES WAS NOT APPLICABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1804274 SODIUM CHLORIDE INHALATION SOLUTION, USP, 0.9% 3ML NEBULIZER (DIRECT PATIENT INTERFACE) CAF THE RITEDOSE CORPORATION 00376204300032

Patients

Seq Age Sex Outcome Treatment
1 66 YR Female Hospitalization ALBUTEROL [SALBUTAMOL].| BREZTRI AEROSPHERE.| FLUTICASONE.| OXYGEN.| PREDNISONE.| SYMBICORT TURBUHALER.| TRELEGY.